Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats

Neuropharmacology

Volumn 39, Issue 1, 2000, Pages 88-98

  Lecca, D ^a   Shim, I ^a   Costa, E ^a   Javaid, J I ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Dopamine; In vivo microdialysis; Lobeline; Mecamylamine; Methyllycaconitine; Nicotine; Nicotinic acetylcholine receptors

Indexed keywords

LOBELINE; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REGIONAL PERFUSION; REINFORCEMENT;

ACONITINE; ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; KINETICS; LOBELINE; MALE; MECAMYLAMINE; MICRODIALYSIS; NERVE ENDINGS; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0033991069     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00085-4     Document Type: Article

References (43)

1. Albuquerque E.X., Alkondon M., Pereira E.F., Castro N.G., Schrattenholz A., Barbosa C.T., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. Journal of Pharmacology and Experimental Therapeutics. 280:1997;1117-1136.
2. Benwell M.E., Balfour D.J. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. British Journal of Pharmacology. 114:1995;454-460.
3. Bhat R.V., Turner S.L., Selvaag S.R., Marks M.J., Collins A.C. Regulation of brain nicotinic receptors by chronic infusion. Journal of Neurochemistry. 56:1991;1932-1939.
4. Brazell M.P., Mitchell S.N., Joseph M.H., Gray J.A. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Psychopharmacology. 29:1990;1177-1185.
5. 7 nicotinic receptor antagonist methyllycaconitine. European Journal of Pharmacology. 301:1996;1-5.
6. Brioni J.D., Decker M.W., Sullivan J.P., Arneric S.P. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Advances in Pharmacology. 17:1997;153-214.
7. Damaj M.I., Patrick G.S., Creasy K.R., Martin B.R. Pharmacology of lobeline, a nicotinic receptor ligand. Journal of Pharmacology and Experimental Therapeutics. 282:1997;410-419.
8. Decker M.W., Brioni J.D., Bannon A.W., Americ S.P. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Science. 56:1995;545-570.
9. Decker M.W., Majchrzak M.J., Arneric S.P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacology Biochemistry Behavior. 45:1993;571-576.
10. Eilers H., Schaeffer P.E., Bickler P.E., Forsayeth J.R. Functional deactivation of the major nicotinic receptor caused by nicotine and protein kinase C-dependent mechanism. Molecular Pharmacology. 52:1997;1105-1112.
11. Fudala P., Iwamoto E. Further studies on nicotine-induced conditioned placed preference in the rat. Pharmacology Biochemistry and Behavior. 25:1986;1041-1049.
12. Giorgi O., Corda M.G., Carboni G., Frau V., Di Chiara G. Effects of cocaine and morphine in rats from two psychogenetically selected lines: a behavioral and brain dialysis study. Behavior Genetics. 27:1997;537-546.
13. Grady S., Marks M.J., Wonnacott S., Collins A.C. Characterization of nicotinic receptor-mediated (3H)-dopamine release from synaptosomes prepared from mouse striatum. Journal of Neurochemistry. 59:1992;848-856.
14. Grady S., Marks M., Collins A. Desensitization of nicotine-stimulated (3H)dopamine release from mouse striatal synaptosomes. Journal of Neurochemistry. 62:1994;1390-1398.
15. Imperato A., Mulas A., Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. European Journal of Pharmacology. 132:1986;337-338.
16. 3H) dopamine release from rat striatal synaptosomes and slices. Journal of Neurochemistry. 70:1998;1069-1076.
17. Keyser K.T., Britto L.R., Schoepfer R., Whiting P., Cooper J., Conroy W., Brozozowska-Prechtl A., Karten H.J., Lindstrom J. Three subtypes of α-bungarotoxin-sensitive nicotinic acetycholine receptors are expressed in chick retina. Journal of Neuroscience. 13:1993;442-454.
18. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Ion Channels. 4:1996;377-449.
19. Marks M.J., Collins A.C. Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzylate. Molecular Pharmacology. 22:1982;554-564.
20. Marks M.J., Pauly J.R., Dross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., Collins A.C. Nicotine binding and nicotine receptor subunit RNA after chronic nicotine treatment. Journal of Neuroscience. 12:1992;2765-2784.
21. Marshall D.L., Redfern P.H., Wonnacott S. Presynaptic nicotine modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naïve and chronic nicotine-treated rats. Journal of Neurochemistry. 68:1997;1511-1519.
22. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annual Review of Physiology. 57:1995;521-546.
23. Mifsud J.-C., Hernandez L., Hoebel B.G. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Research. 478:1989;365-367.
24. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotine receptors in the ventral tegmental area. Synapse. 16:1994;36-44.
25. 7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. Journal of Neuroscience. 17:1997;9165-9171.
26. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1987;Academic, Sydney.
27. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404.
28. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;255-257.
29. 3H)(-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology. 27:1988;235-241.
30. Reavill C., Walthjer B., Stolerman I.P., Testa B. Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology. 29:1990;619-624.
31. Rowell P.P., Hillebrand J.A. Characterization of nicotine-induced desensitization of evoked dopamine release from striatal synaptosomes. Journal of Neurochemistry. 63:1994;561-569.
32. 3H)acetylcholine recognition sites in brain by nicotinic cholinergic drugs. Journal of Neurochemistry. 45:1985;427-433.
33. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties and distribution of rat brain alpha 7; a nicotine cation channel highly permeable to calcium. Journal of Neuroscience. 13:1993;596-604.
34. 3H)dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine. Journal of Neurochemistry. 71:1997;258-265.
35. Toth E., Sershen H., Hashim A., Vizi E.S., Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions, role of glutamic acid. Neurochemical Research. 17:1992;265-271.
36. Varanda W.A., Aracava Y., Sherby S.M., VanMeter W.G., Eldefrawi M.E., Albuquerque E.X. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Molecular Pharmacology. 28:1985;128-137.
37. Vernino S., Amador M., Luetje C.W., Patrick J., Dani J.A. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron. 8:1992;127-134.
38. 2+. Neuron. 8:1992;353-362.
39. Ward J.M., Cockroft V.B., Lunt G.G., Smille F.S., Wonnacott S. Methylylcaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS. 270:1990;45-48.
40. Wonnacott S. α-Bungarotoxin binds to low affinity nicotine binding sites in rat brain. Journal of Neurochemistry. 37:1986;1706-1712.
41. Wonnacott S. The paradox of nicotine acetylcholine receptor up-regulation by nicotine. Trends in Pharmacological Science. 11:1990;216-219.
42. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends in Neuroscience. 20:1997;92-98.
43. Zoli M., Lena C., Piccioto M.R., Changeux J.-P. Identification of four classes of brain nicotinic receptors using β2 mutant mouse. Journal of Neuroscience. 18:1998;4461-4472.